Earnings History Data for Vivos Therapeutics, Inc. (VVOS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vivos Therapeutics, Inc.

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-05-2025	PM		VVOS	Vivos Therapeutics, Inc.	18.49	-0.45	-0.44	-1.63	Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M [5/16/2025 4:03 AM]	2.58	-0.48 (-15.69%)	2.93	-0.13 (-4.25%)	1.91 - 6.28	335,660	70,000	14,393
Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 [5/15/2025 7:32 PM] Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M [5/16/2025 4:03 AM] Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates [May-15-25 06:00PM] Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update [May-15-25 04:20PM]
31-03-2025	AH		VVOS	Vivos Therapeutics, Inc.	15.42	-0.28	-0.43	-3.05	Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M [3/31/2025 4:22 PM]	2.60	-0.25 (-8.77%)	2.83	-0.02 (-0.70%)	1.91 - 6.28	159,392	70,000	3,180
Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M [3/31/2025 4:22 PM] Vivos therapeutics outlines expansion of sleep center alliances with $4,500 revenue per patient potential [4/1/2025 12:18 AM] Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update [2025-03-31 04:20PM] Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call [Mar-28-25 08:30AM]
14-11-2024	AH		VVOS	Vivos Therapeutics	15.00	-0.40	-0.70	0.00	Vivos Therapeutics GAAP EPS of -$0.40, revenue of $3.86M [11/15/2024 10:02 AM]	2.86	-0.26 (-8.33%)	3.02	-0.10 (-3.20%)	1.91 - 48.79	218,663	180,000	3,458
Vivos Therapeutics GAAP EPS of -$0.40, revenue of $3.86M [11/15/2024 10:02 AM] Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... [2024-11-15 04:00AM] Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update [Nov-14-24 04:05PM]
14-11-2023	AH		VVOS	Vivos Therapeutics, Inc.	3.28	-1.75	-3.25	-6.50	Vivos Therapeutics GAAP EPS of -$1.75 beats by $1.38, revenue of $3.3M misses by $0.84M [11/14/2023 4:18 PM]	3.87	0.14 (3.75%)	4.17	0.44 (11.80%)	2.73 - 74.05	71,290	50,000	1,358
Vivos Therapeutics GAAP EPS of -$1.75 beats by $1.38, revenue of $3.3M misses by $0.84M [11/14/2023 4:18 PM]
14-08-2023	AH		VVOS	Vivos Therapeutics, Inc.	10.27	-0.20	-0.15	-0.33		0.3267	-0.02 (-4.78%)	0.33	-0.01 (-3.00%)	0.23 - 2.96	354,942	8,370,000	67,725

08-06-2023	AH	4:15 PM ET (Jun 8)	VVOS	Vivos Therapeutics, Inc.	12.25	-0.20	-0.17	-0.26	Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.10, revenue of $3.86M misses by $0.15M [6/8/2023 4:22 PM]	0.4222	-0.05 (-10.17%)	0.46	-0.01 (-2.00%)	0.30 - 2.96	219,180	140,000	13,774
Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.10, revenue of $3.86M misses by $0.15M [6/8/2023 4:22 PM]
30-03-2023	PM	4:15 PM ET (Mar 30)	VVOS	Vivos Therapeutics, Inc.	18.76	-0.20	-0.22	-0.34	Vivos Therapeutics GAAP EPS of -$1.04, revenue of $16.02M [3/31/2023 3:03 AM]	0.3410	-0.02 (-5.28%)	0.34	-0.02 (-5.00%)	0.30 - 2.96	308,785	170,000	4,552
Vivos Therapeutics GAAP EPS of -$1.04, revenue of $16.02M [3/31/2023 3:03 AM]
20-12-2022	AH	4:05 PM ET (Dec 20)	VVOS	Vivos Therapeutics, Inc.	8.02	-0.33	-0.25	-0.26	Vivos Therapeutics GAAP EPS of -$0.26, revenue of $4.2M [12/20/2022 4:21 PM]	0.4111	-0.12 (-22.43%)	0.48	-0.05 (-8.68%)	0.34 - 3.69	340,764	170,000	19,188
Vivos Therapeutics GAAP EPS of -$0.26, revenue of $4.2M [12/20/2022 4:21 PM]
16-05-2022	AH	4:05 PM ET (May 16)	VVOS	Vivos Therapeutics, Inc.	29.69	-0.26	-0.29	-0.19	Vivos Therapeutics GAAP EPS of -$0.26 in-line, revenue of $3.46M misses by $0.98M [5/16/2022 4:11 PM]	1.57	0.22 (16.01%)	0.0	0.0 (0.00%)	1.18 - 7.09	147,236	110,000	0
Vivos Therapeutics GAAP EPS of -$0.26 in-line, revenue of $3.46M misses by $0.98M [5/16/2022 4:11 PM] Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update [May-16-22 04:05PM]
15-11-2021	AH	4:05 PM ET (Nov 15)	VVOS	Vivos Therapeutics, Inc.	89.42	-0.26	-0.16	0.00	Vivos Therapeutics EPS misses by $0.08, beats on revenue [11/15/2021 4:20 PM]	3.25	-0.81 (-19.95%)	3.56	-0.50 (-12.32%)	2.61 - 14.41	499,213	80,000	3,170
Vivos Therapeutics EPS misses by $0.08, beats on revenue [11/15/2021 4:20 PM] Vivos Therapeutics to Participate at the Q4 Virtual Investor Summit [Nov-15-21 07:00AM] Vivos Therapeutics Reports Third Quarter 2021 Financial Results and Operational Update [Nov-15-21 04:05PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	VVOS	Vivos Therapeutics, Inc.	63.87	-0.19	-0.16	0.00		3.28	0.54 (19.71%)	2.80	0.06 (2.19%)	2.61 - 14.41	3,130,127	230,000	10,708
Vivos Therapeutics Reports Second Quarter 2021 Financial Results and Operational Update [Aug-12-21 04:05PM]
17-05-2021	AH	4:05 PM ET (May 17)	VVOS	Vivos Therapeutics, Inc.	103.60	-0.19	-0.17	0.00	Vivos Therapeutics EPS misses by $0.02, beats on revenue [5/17/2021 4:23 PM]	5.79	-0.27 (-4.46%)	6.16	0.10 (1.65%)	5.64 - 14.41	94,374	310,000	1,300
Vivos Therapeutics EPS misses by $0.02, beats on revenue [5/17/2021 4:23 PM] What Type Of Shareholders Own The Most Number of Vivos Therapeutics, Inc. (NASDAQ:VVOS) Shares? [May-14-21 07:27AM] Vivos Therapeutics Inc to Host Earnings Call [May-17-21 03:15PM] Vivos Therapeutics Reports First Quarter 2021 Financial Results and Operational Update [May-17-21 04:05PM]
25-03-2021	AH	After the close (Mar 25)	VVOS	Vivos Therapeutics, Inc.	122.50	-0.48	-0.21	0.00	Vivos Therapeutics EPS misses by $0.93, beats on revenue [3/25/2021 4:54 PM]	6.93	0.09 (1.32%)	7.45	0.61 (8.92%)	5.64 - 14.41	54,828	140,000	15,505
Vivos Therapeutics EPS misses by $0.93, beats on revenue [3/25/2021 4:54 PM] Vivos Therapeutics Inc to Host Earnings Call [Mar-25-21 03:15PM] Vivos Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Update [Mar-25-21 04:05PM]